# VORICONAZOLE
> **ANDA211264** · Abbreviated New Drug Application (Generic) · Sponsor: UBI · Approved 2023-03-09
## Drug
- **FDA Application Number:** ANDA211264
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** VORICONAZOLE
- **Generic name:** VORICONAZOLE
- **Active ingredients:** VORICONAZOLE
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** UBI
- **Manufacturer:** UBI Pharma Inc.
- **First approval:** 2023-03-09
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211264)
---
*AI Analytics · CC0 1.0*